Skip to main content
Clinical Trials/NCT03947268
NCT03947268
Completed
N/A

Palliative Short-course Radiotherapy in Advanced Pelvic Cancer: a Phase II Study (SHARON Project)

IRCCS Azienda Ospedaliero-Universitaria di Bologna0 sites25 target enrollmentJanuary 1, 2009
ConditionsPalliative Care

Overview

Phase
N/A
Intervention
Not specified
Conditions
Palliative Care
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
25
Primary Endpoint
Assessment of symptoms [pain]
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The study wants to define the safety and efficacy of a short-course radiation therapy in patients with symptomatic advanced pelvic cancer.

Detailed Description

he study wants to define the safety and efficacy of a short course accelerated radiation therapy delivered in twice daily fractions and 2 consecutive days for symptomatic palliation of advanced solid cancer.

Registry
clinicaltrials.gov
Start Date
January 1, 2009
End Date
January 1, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alessio Giuseppe Morganti

Professor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility Criteria

Inclusion Criteria

  • histologically proven advanced pelvic cancer
  • excluded from curative therapy because of disease stage and/or presence of multiple comorbidities and/or poor performance status
  • age \> 18 years
  • Eastern Cooperative Oncology Group (ECOG) \<3

Exclusion Criteria

  • prior radiotherapy to the same region

Outcomes

Primary Outcomes

Assessment of symptoms [pain]

Time Frame: 1 year]

Pain after treatment is evaluated with the Visual Analogic scale (VAS). Values range from 0 (no pain) to 10 (maximum possible pain).

Secondary Outcomes

  • Incidence of Treatment-Emergent Adverse Events [Acute radiation toxicity](1 year)
  • Incidence of Treatment-Emergent Adverse Events [Late radiation toxicity](1 year)
  • Assessment of the Quality of life (QOL)(1 year)

Similar Trials